Specifically, participants in the depression (306/1267, 24.15%; odds ratio [OR] 0.78, 95% CI 0.62-0.98; P=.03), PTSD (294/1215, 24.19%; OR 0.78, 95% CI 0.62-0.98; P=.03), PD (229/1003, 22.83%; OR 0.73, 95% CI 0.57-0.92; P=.009), and two or more ADS (323/1332, 24.25%; OR 0.78, 95% CI 0.62-0.98; P=.03) groups exhibited statistically lower quit rates of 20% to 25% relative magnitude than the no ADS group; those who screened positive for GAD (195/792, 24.6%; P=.08) and SAD (176/696, 25.3%; P=.13) did not. The gene discussed is GAD1; the disease is depressive disorder.